135 related articles for article (PubMed ID: 35385527)
1. Mutations in the acetylation hotspots of Rbl2 are associated with increased risk of breast cancer.
Ullah F; Khurshid N; Fatimi Q; Loidl P; Saeed M
PLoS One; 2022; 17(4):e0266196. PubMed ID: 35385527
[TBL] [Abstract][Full Text] [Related]
2. In vitro phosphorylation and acetylation of the murine pocket protein Rb2/p130.
Saeed M; Schwarze F; Loidl A; Meraner J; Lechner M; Loidl P
PLoS One; 2012; 7(9):e46174. PubMed ID: 23029429
[TBL] [Abstract][Full Text] [Related]
3. RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.
Pentimalli F; Forte IM; Esposito L; Indovina P; Iannuzzi CA; Alfano L; Costa C; Barone D; Rocco G; Giordano A
Oncogene; 2018 Jul; 37(27):3657-3671. PubMed ID: 29606701
[TBL] [Abstract][Full Text] [Related]
4. Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer.
Ullah F; Khan T; Ali N; Malik FA; Kayani MA; Shah ST; Saeed M
PLoS One; 2015; 10(8):e0134687. PubMed ID: 26271034
[TBL] [Abstract][Full Text] [Related]
5. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.
De Falco G; Leucci E; Lenze D; Piccaluga PP; Claudio PP; Onnis A; Cerino G; Nyagol J; Mwanda W; Bellan C; Hummel M; Pileri S; Tosi P; Stein H; Giordano A; Leoncini L
Blood; 2007 Aug; 110(4):1301-7. PubMed ID: 17485552
[TBL] [Abstract][Full Text] [Related]
6. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2.
Enrico TP; Stallaert W; Wick ET; Ngoi P; Wang X; Rubin SM; Brown NG; Purvis JE; Emanuele MJ
Elife; 2021 Dec; 10():. PubMed ID: 34851822
[TBL] [Abstract][Full Text] [Related]
7. High incidence of allelic loss at 16q12.2 region spanning RBL2/p130 gene in retinoblastoma.
Priya K; Jada SR; Quah BL; Quah TC; Lai PS
Cancer Biol Ther; 2009 Apr; 8(8):714-7. PubMed ID: 19252413
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-dependent acetylation of Rb2/p130 in NIH3T3 cells.
Schwarze F; Meraner J; Lechner M; Loidl A; Stasyk T; Laich A; Loidl P
Oncogene; 2010 Oct; 29(42):5755-60. PubMed ID: 20676144
[TBL] [Abstract][Full Text] [Related]
9. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
[TBL] [Abstract][Full Text] [Related]
10. Nucleosomes positioning around transcriptional start site of tumor suppressor (Rbl2/p130) gene in breast cancer.
Farman FU; Iqbal M; Azam M; Saeed M
Mol Biol Rep; 2018 Apr; 45(2):185-194. PubMed ID: 29417345
[TBL] [Abstract][Full Text] [Related]
11. RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.
Samra N; Toubiana S; Yttervik H; Tzur-Gilat A; Morani I; Itzkovich C; Giladi L; Abu Jabal K; Cao JZ; Godley LA; Mory A; Baris Feldman H; Tveten K; Selig S; Weiss K
J Hum Genet; 2021 Nov; 66(11):1101-1112. PubMed ID: 33980986
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
13. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.
Zhu Y; Gu J; Li Y; Peng C; Shi M; Wang X; Wei G; Ge O; Wang D; Zhang B; Wu J; Zhong Y; Shen B; Chen H
Cancer Lett; 2018 Jan; 412():59-68. PubMed ID: 28987387
[TBL] [Abstract][Full Text] [Related]
14. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
15. Orbital nodular fasciitis in child with biallelic germline RBL2 variant.
Rips J; Abu-Libdeh B; Koplewitz BZ; Kehat-Ophir S; Frenkel S; Elpeleg O; Harel T
Eur J Med Genet; 2022 Jun; 65(6):104513. PubMed ID: 35487417
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta induced RBL2 expression in renal cancer cells by down-regulating miR-93.
Shi J; Zhuang Y; Liu XK; Zhang YX; Zhang Y
Clin Transl Oncol; 2014 Nov; 16(11):986-92. PubMed ID: 25183046
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase.
Terashima M; Ishimura A; Yoshida M; Suzuki Y; Sugano S; Suzuki T
Biochem Biophys Res Commun; 2010 Aug; 399(2):238-44. PubMed ID: 20650264
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3 phosphorylates RBL2/p130 during quiescence.
Litovchick L; Chestukhin A; DeCaprio JA
Mol Cell Biol; 2004 Oct; 24(20):8970-80. PubMed ID: 15456871
[TBL] [Abstract][Full Text] [Related]
19. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
Nor Rashid N; Yong ZL; Yusof R; Watson RJ
Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
[TBL] [Abstract][Full Text] [Related]
20. pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda.
Kalungi S; Steine SJ; Wabinga H; Bostad L; Molven A
BMC Clin Pathol; 2009 Aug; 9():6. PubMed ID: 19691827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
